4 completed, 1 active not recruiting, 1 recruiting. 6 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 4, Active not recruiting 1, Recruiting 1 |
| Phase 2 | 3 | Completed 2, Recruiting 1 |
Follow Prostatic Neoplasm: new trials by email Literature Review of Prostatic Neoplasm trials Research Report on Prostatic Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PSMA PET Combined With MRI for the Detection of PCa 68Ga-PSMA-11 - PCA, Prostate Cancer | Phase 3 | Active not recruiting | Telix Pharmaceuticals (Innovations) Pty Limited | 338 | 2025-08-18 | 2026-10-20 |
| DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations Trastuzumab, Pertuzumab - Haematological Malignancy, Colorectal Neoplasms | Phase 2 / Phase 3 | Recruiting | Cancer Research UK | 30 | 2023-03-07 | 2025-12-02 |
| 68Ga PSMA PET for Patients With Biochemical Recurrence of Prostate Cancer Ga-68 PSMA-HBED-CC PET - Prostate Cancer, Prostatic Neoplasm | Phase 2 / Phase 3 | Completed | Michael Graham PhD, MD | 30 | 2018-02-16 | 2024-07-12 |
| 68Ga PSMA in Preprostatectomy Patients Ga-68 PSMA-HBED-CC PET - Prostate Cancer, Prostatic Neoplasm | Phase 2 / Phase 3 | Completed | Michael Graham PhD, MD | 22 | 2018-02-16 | 2024-02-15 |
| Efficacy and Safety of a Triptorelin 6-month Formulation in Patients With Advanced Prostate Cancer triptorelin embonate (INN) - Prostatic Neoplasm | Phase 3 | Completed | Debiopharm International SA | 120 | 2006-07-01 | 2014-07-25 |
| Pd-103 Dose De-Escalation for Early Stage Prostate Cancer: A Prospective Randomized Trial Pd-103 - Prostatic Neoplasm | Phase 3 | Completed | Schiffler Cancer Center | 319 | 2005-10-01 | 2015-11-17 |
Prostatic Neoplasms (6) · Prostatic Neoplasms, Castration-Resistant (2) · Colorectal Neoplasms (1) · Gallbladder Neoplasms (1) · Hematologic Neoplasms (1) · Lung Neoplasms (1) · Neoplasms (1) · Ovarian Neoplasms (1) · Pancreatic Neoplasms (1) · Salivary Gland Neoplasms (1) · Skin Neoplasms (1) · Urinary Bladder Neoplasms (1)
Genital Diseases (6) · Genital Diseases, Male (6) · Genital Neoplasms, Male (6) · Male Urogenital Diseases (6) · Neoplasms by Site (6) · Prostatic Diseases (6) · Urogenital Diseases (6) · Urogenital Neoplasms (6) · Neoplasms (5) · Adnexal Diseases (1) · Biliary Tract Diseases (1) · Biliary Tract Neoplasms (1) · Colonic Diseases (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1)
Palladium-103 (1) · Trastuzumab (1) · Triptorelin Pamoate (1) · gallium 68 PSMA-11 (1) · pertuzumab (1)
Michael Graham PhD, MD (2) · Cancer Research UK (1) · Debiopharm International SA (1) · Schiffler Cancer Center (1) · Telix Pharmaceuticals (Innovations) Pty Limited (1)
United States (4) · Australia (1) · South Africa (1) · United Kingdom (1)
Gregory S. Merrick, MD (1) · Kent E. Wallner, MD (1) · Matthew Krebs, Dr (1) · Michael Graham, MD, PhD (1) · Michael M. Graham, MD, PhD (1)